Citations (27)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Mario L. Marques-Piubelli, Ellen J. Schlette, Joseph D. Khoury, Fateeha Furqan, Francisco Vega, Luisa M. Solis Soto, Ignacio I. Wistuba, William G. Wierda, Marina Konopleva, Alessandra Ferrajoli & Paolo Strati. (2021) Expression of BCL2 alternative proteins and association with outcome in CLL patients treated with venetoclax. Leukemia & Lymphoma 62:5, pages 1129-1135.
Read now
Read now
Elizabeth S. Henson, James B. Johnston & Spencer B. Gibson. (2008) The role of TRAIL death receptors in the treatment of hematological malignancies. Leukemia & Lymphoma 49:1, pages 27-35.
Read now
Read now
Burhan Turgut, Ozden Vural, Funda S. Pala, Gülsüm E. Pamuk, Kiymet TabakcioĞlu, Muzaffer Demir, Şeniz Öngören, Teoman Soysal & Çetin Algüneş. (2007) 17p Deletion is associated with resistance of B-cell chronic lymphocytic leukemia cells to in vitro fludarabine-induced apoptosis. Leukemia & Lymphoma 48:2, pages 311-320.
Read now
Read now
Articles from other publishers (24)
Stefania Bottardi, Romain Guieze, Vincent Bourgoin, Nasser Fotouhi-Ardakani, Aurore Dougé, Anaïs Darracq, Yahia A. Lakehal, Marc G. Berger, Luigina Mollica, Jacques-Olivier Bay, James G. Omichinski & Eric Milot. (2020) MNDA controls the expression of MCL-1 and BCL-2 in chronic lymphocytic leukemia cells. Experimental Hematology 88, pages 68-82.e5.
Crossref
Crossref
Edo Kon, Inbal Hazan-Halevy, Daniel Rosenblum, Niv Cohen, Sushmita Chatterjee, Nuphar Veiga, Pia Raanani, Osnat Bairey, Ohad Benjamini, Arnon Nagler & Dan Peer. (2020) Resveratrol Enhances mRNA and siRNA Lipid Nanoparticles Primary CLL Cell Transfection. Pharmaceutics 12:6, pages 520.
Crossref
Crossref
Annalisa Lonetti, Alessandra Cappellini, Alice Bertaina, Franco Locatelli, Andrea Pession, Francesca Buontempo, Camilla Evangelisti, Cecilia Evangelisti, Ester Orsini, Laura Zambonin, Luca Maria Neri, Alberto Maria Martelli & Francesca Chiarini. (2016) Improving nelarabine efficacy in T cell acute lymphoblastic leukemia by targeting aberrant PI3K/AKT/mTOR signaling pathway. Journal of Hematology & Oncology 9:1.
Crossref
Crossref
Suliman A. Alsagaby, Paul Brennan & Chris Pepper. (2016) Key Molecular Drivers of Chronic Lymphocytic Leukemia. Clinical Lymphoma Myeloma and Leukemia 16:11, pages 593-606.
Crossref
Crossref
Kristine L. Holm, Randi L. Indrevaer, June Helen Myklebust, Arne Kolstad, Jan Øivind Moskaug, Elin H. Naderi & Heidi K. Blomhoff. (2016) Myeloid cell leukaemia 1 has a vital role in retinoic acid-mediated protection of Toll-like receptor 9-stimulated B cells from spontaneous and DNA damage-induced apoptosis. Immunology 149:1, pages 62-73.
Crossref
Crossref
S Baig, I Seevasant, J Mohamad, A Mukheem, H Z Huri & T Kamarul. (2016) Potential of apoptotic pathway-targeted cancer therapeutic research: Where do we stand?. Cell Death & Disease 7:1, pages e2058-e2058.
Crossref
Crossref
Duong Nhu, Guillaume Lessene, David C. S. Huang & Christopher J. Burns. (2016) Small molecules targeting Mcl-1: the search for a silver bullet in cancer therapy. MedChemComm 7:5, pages 778-787.
Crossref
Crossref
JOLANTA D. ŻOŁNIERCZYK, ARLETA BOROWIAK, PAWEŁ HIKISZ, BARBARA CEBULA-OBRZUT, JERZY Z. BŁOŃSKI, PIOTR SMOLEWSKI, TADEUSZ ROBAK & ZOFIA M. KILIAŃSKA. (2013) Promising anti-leukemic activity of atorvastatin. Oncology Reports 29:5, pages 2065-2071.
Crossref
Crossref
Jolanta D. Żołnierczyk, Arleta Borowiak, Jerzy Z. Błoński, Barbara Cebula-Obrzut, Małgorzata Rogalińska, Aleksandra Kotkowska, Ewa Wawrzyniak, Piotr Smolewski, Tadeusz Robak & Zofia M. Kiliańska. (2013) In vivo and ex vivo responses of CLL cells to purine analogs combined with alkylating agent. Pharmacological Reports 65:2, pages 460-475.
Crossref
Crossref
Denis Drygin. 2013. Protein Kinase CK2. Protein Kinase CK2
383
439
.
Guihua Sun, Haitang Li, Xiwei Wu, Maricela Covarrubias, Lisa Scherer, Keith Meinking, Brian Luk, Pritsana Chomchan, Jessica Alluin, Adrian F. Gombart & John J. Rossi. (2012) Interplay between HIV-1 infection and host microRNAs. Nucleic Acids Research 40:5, pages 2181-2196.
Crossref
Crossref
John C. Allen, Fatima Talab, Mirko Zuzel, Ke Lin & Joseph R. Slupsky. (2011) c-Abl regulates Mcl-1 gene expression in chronic lymphocytic leukemia cells. Blood 117:8, pages 2414-2422.
Crossref
Crossref
Sara Samuel, Vanessa F Tumilasci, Stephanie Oliere, Thi Liên-Anh Nguyên, April Shamy, John Bell & John Hiscott. (2010) VSV Oncolysis in Combination With the BCL-2 Inhibitor Obatoclax Overcomes Apoptosis Resistance in Chronic Lymphocytic Leukemia. Molecular Therapy 18:12, pages 2094-2103.
Crossref
Crossref
Maike Buchner, Philipp Brantner, Natalie Stickel, Gabriele Prinz, Meike Burger, Constance Bär, Christine Dierks, Dietmar Pfeifer, Ariane Ott, Roland Mertelsmann, John G. Gribben, Hendrik Veelken & Katja Zirlik. (2010) The microenvironment differentially impairs passive and active immunotherapy in chronic lymphocytic leukaemia - CXCR4 antagonists as potential adjuvants for monoclonal antibodies. British Journal of Haematology 151:2, pages 167-178.
Crossref
Crossref
Y M Mowery, J B Weinberg, M N Kennedy, K M Bond, J O Moore, M C Lanasa, J P Gockerman, L F Diehl, S V Pizzo, G J Cianciolo & D R Friedman. (2010) LMP-420: a novel purine nucleoside analog with potent cytotoxic effects for CLL cells and minimal toxicity for normal hematopoietic cells. Leukemia 24:9, pages 1580-1587.
Crossref
Crossref
Shogo Kojima, Akira Hyakutake, Nobuko Koshikawa, Akira Nakagawara & Keizo Takenaga. (2010) MCL-1V, a novel mouse antiapoptotic MCL-1 variant, generated by RNA splicing at a non-canonical splicing pair. Biochemical and Biophysical Research Communications 391:1, pages 492-497.
Crossref
Crossref
Malgorzata Rogalinska, Pawel Goralski, Katarzyna Wozniak, Jolanta D. Bednarek, Jerzy Z. Blonski, Tadeusz Robak, Henryk Piekarski, Margaret Hanausek, Zbigniew Walaszek & Zofia M. Kilianska. (2009) Calorimetric study as a potential test for choosing treatment of B-cell chronic lymphocytic leukemia. Leukemia Research 33:2, pages 308-314.
Crossref
Crossref
George A. CalinAmelia CimminoMuller Fabbri, Manuela Ferracin, Sylwia E. Wojcik, Masayoshi ShimizuCristian Taccioli, Nicola Zanesi, Ramiro Garzon, Rami I. Aqeilan, Hansjuerg Alder, Stefano Volinia, Laura Rassenti, Xiuping Liu, Chang-gong Liu, Thomas J. Kipps, Massimo Negrini & Carlo M. Croce. (2008) MiR-15a and miR-16-1 cluster functions in human leukemia. Proceedings of the National Academy of Sciences 105:13, pages 5166-5171.
Crossref
Crossref
A Olsson, M Norberg, A ökvist, K Derkow, A Choudhury, G Tobin, F Celsing, A österborg, R Rosenquist, M Jondal & L M Osorio. (2007) Upregulation of bfl-1 is a potential mechanism of chemoresistance in B-cell chronic lymphocytic leukaemia. British Journal of Cancer 97:6, pages 769-777.
Crossref
Crossref
Anthony W. Tolcher & Anthony W. Tolcher. 2007. Lung Cancer. Lung Cancer
123
148
.
Elizabeth S. Henson, Xiaojie Hu & Spencer B. Gibson. (2006) Herceptin Sensitizes ErbB2–Overexpressing Cells to Apoptosis by Reducing Antiapoptotic Mcl-1 Expression. Clinical Cancer Research 12:3, pages 845-853.
Crossref
Crossref
David Hui, Natasha Satkunam, Moayad Al Kaptan, Tony Reiman & Raymond Lai. (2006) Pathway-specific apoptotic gene expression profiling in chronic lymphocytic leukemia and follicular lymphoma. Modern Pathology 19:9, pages 1192-1202.
Crossref
Crossref
G Tobin, Å Skogsberg, U Thunberg, A Laurell, A Åleskog, M Merup, C Sundström, G Roos, K Nilsson & R Rosenquist. (2005) Mcl-1 gene promoter insertions do not correlate with disease outcome, stage or VH gene mutation status in chronic lymphocytic leukaemia. Leukemia 19:5, pages 871-873.
Crossref
Crossref
Ronit Rotem, Alina Heyfets, Orit Fingrut, Dorit Blickstein, Mati Shaklai & Eliezer Flescher. (2005) Jasmonates: Novel Anticancer Agents Acting Directly and Selectively on Human Cancer Cell Mitochondria. Cancer Research 65:5, pages 1984-1993.
Crossref
Crossref